Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kinji Hashimoto is active.

Publication


Featured researches published by Kinji Hashimoto.


Tetrahedron-asymmetry | 1995

Asymmetric synthesis of a xanthine dehydrogenase inhibitor (S)-(−)-BOF-4272: Utility of chiral alkoxysulfonium salts

Masato Matsugi; Kinji Hashimoto; Masatoshi Inai; Norio Fukuda; Takuya Furuta; Jun-ichi Minamikawa; Sei Otsuka

Abstract A practical synthetic method for a xanthine dehydrogenase inhibitor, ( S )-(−)-BOF-4272, was established utilizing an asymmetric oxidation of diaryl sulfide BOF-4269. The oxidation of the sulfide with 1-chlorobenzotriazole carried out in the presence of 4-cyanopyridine and chiral 2-phenylcyclohexanol gave a high enantiomeric excess (73% ee ). The sulfoxides in each enantiomerically pure form could be obtained by treating with alkaline hydrolysis or thermolysis of one the diastereomeric intermediate sulfonium salts (>99% de ). Thus the transformation into the sulfoxides occur with virtually perfect inversion (alkaline hydrolysis) or retention (thermolysis). It is therefore possible to obtain the target sulfoxide, ( S )-(−)-BOF-4272, from both the two diastereomeric sulfonium intermediates.


Phosphorus Sulfur and Silicon and The Related Elements | 1997

Asymmetric Synthesis of a Xanthine Dehydrogenase Inhibitor (S)-(–)-BOF-4272 : Mechanism of Chiral Diaryl Sulfoxide Formation

Kinji Hashimoto; Masato Matsugi; Norio Fukuda; Yasuhisa Kurogi

A pyrazolotriazine derivative (BOF-4272), a potent xanthine dehydrogenase inhibitor, was synthesized in good yield via 9 steps from vanillin. The asymmetric synthesis was achieved effectively by a modified Oaes asymmetric oxidation of diaryl sulfide. A mechanism involving pentacoordinated sulfurane intermediates was supported by the molecular modeling.


Archive | 1995

PYRAZOLO [1,5-a]PYRIMIDINE DERIVATIVE

Yasuo Shoji; Makoto Inoue; Takashi Okamura; Kinji Hashimoto; Masayuki Ohara; Tsuneo Yasuda


Bioorganic & Medicinal Chemistry Letters | 2004

Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma.

Takashi Okamura; Yasuhisa Kurogi; Kinji Hashimoto; Seiji Sato; Hiroshi Nishikawa; Kimio Kiryu; Yoshimitsu Nagao


Journal of Medicinal Chemistry | 2001

Discovery of novel mesangial cell proliferation inhibitors using a three-dimensional database searching method.

Yasuhisa Kurogi; Kazuyoshi Miyata; Takashi Okamura; Kinji Hashimoto; Kazuhiko Tsutsumi; Masahiro Nasu; Matsuko Moriyasu


Journal of Medicinal Chemistry | 2002

1,2,4-Triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A(3) receptor ligands.

Takashi Okamura; Yasuhisa Kurogi; Hiroshi Nishikawa; Kinji Hashimoto; Hiroshi Fujiwara; Yoshimitsu Nagao


Archive | 1991

PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND ANTI-INFLAMMATORY CONTAINING THE SAME

Makoto Inoue; Kinji Hashimoto; Toshiko Kuwahara; Yukio Sugimoto; Takuji Uesako; Toshiaki Funato


Archive | 1991

Pyrazolo[1,5-a]pyrimidine derivatives and anti-inflammatory agent containing the same

Makoto Inoue; Kinji Hashimoto; Toshiko Kuwahara; Yukio Sugimoto; Takuji Uesako; Toshiaki Funato


Archive | 1989

Video signal coder

Takumi Hasebe; Kinji Hashimoto; Hiroshi Nishikawa; Shoichi Nishino; 欽司 橋本; 浩 西川; 正一 西野; 巧 長谷部


Bioorganic & Medicinal Chemistry Letters | 2004

Facile synthesis of fused 1,2,4-triazolo[1,5-c]pyrimidine derivatives as human adenosine A3 receptor ligands.

Takashi Okamura; Yasuhisa Kurogi; Kinji Hashimoto; Hiroshi Nishikawa; Yoshimitsu Nagao

Collaboration


Dive into the Kinji Hashimoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge